New RFI Seeks Prophylactic Platforms for Medical Countermeasure Development
The Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND), through its Accelerated Defense Pharmaceuticals (ADP) program, has issued a Request for Information (RFI) on Prophylactic Platform Technologies for Medical Countermeasures. The government seeks input from commercial and academic product developers with platforms that could accelerate protection against priority chemical, biological, radiological,
New RFI Seeks Prophylactic Platforms for Medical Countermeasure Development Read More »